Prostaglandin E2 enhances bradykinin-stimulated release of neuropeptides from rat sensory neurons in culture

Journal of Neuroscience

Volumn 14, Issue 8, 1994, Pages 4987-4997

  Vasko, M R ^a   Campbell, W B ^b   Waite, K J ^a  

^a INDIANA UNIVERSITY   (United States)

^b MEDICAL COLLEGE OF WISCONSIN   (United States)

Author keywords

bradykinin; calcitonin gene related peptide; dorsal root ganglia; prostaglandin E2; release; sensory neuron; substance P

Indexed keywords

ARACHIDONIC ACID; BRADYKININ; CALCITONIN GENE RELATED PEPTIDE; CALCIUM; ICOSANOID; PROSTAGLANDIN E2; PROSTAGLANDIN F2; PROSTAGLANDIN SYNTHASE; SUBSTANCE P; INDOMETACIN;

ANIMAL TISSUE; ARTICLE; CALCIUM CELL LEVEL; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVITY; ETIOLOGY; HYPERALGESIA; IMMUNOREACTIVITY; INFLAMMATION; NOCICEPTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN SECRETION; RAT; SENSORY NERVE; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; METABOLISM; PREGNANCY; RADIOIMMUNOASSAY; RAT STRAIN; SENSORY NERVE CELL; SPINAL GANGLION;

ANIMAL; BRADYKININ; CALCITONIN GENE-RELATED PEPTIDE; CELLS, CULTURED; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DINOPROSTONE; DRUG SYNERGISM; FEMALE; GANGLIA, SPINAL; INDOMETHACIN; NEURONS, AFFERENT; PREGNANCY; RADIOIMMUNOASSAY; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE P; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0028169759     PISSN: 02706474     EISSN: None     Source Type: Journal    
DOI: 10.1523/jneurosci.14-08-04987.1994     Document Type: Article

References (68)

1. Andreeva L, Rang HP (1993) Effect of bradykinin and prostaglandins on the release of calcitonin gene-related peptide-like immunoreactivity from the rat spinal cord in vivo. Br J Pharmacol 108:185-190.
2. Baccaglini PI, Hogan PG (1983) Some rat sensory neurons in culture express characteristics of differentiated pain sensory cells. Proc Natl Acad Sci USA 80:594-598.
3. Bayliss WM (1901) On the origin from the spinal cord of the vasodilator fibres of the hindlimb and on the nature of these fibres. J Physiol (Lond) 26:173-209.
4. Beck PW, Handwerker HO (1974) Bradykinin and serotonin effects on various types of cutaneous nerve fibres. Pfluegers Arch 347:209-222.
5. Besson J-M, Chaouch A (1987) Peripheral and spinal mechanisms of nociception. Physiol Rev 67:67-186.
6. Bombardier S, Cattani P, Ciabattoni G, Di Munno O, Pasero G, Patrono C, Pinca E, Pugliese F (1981) The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs. Br J Pharmacol 73:893-901.
7. Caldwell PC (1970) Calcium chelation and buffers. In: Calcium and cellular function (Cuthbert AW, ed), pp 11-16. New York: St. Martin.
8. 1 on rat cutaneous afferent nerve activity. Br J Pharmacol 59:343-347.
9. Cuello AC (1987) Peptides as neuromodulators in primary sensory neurons. Neuropharmacology 26:971-979.
10. Dray A, Perkins M (1993) Bradykinin and inflammatory pain. Trends Neurosci 16:99-104.
11. Ferreira SH (1972) Prostaglandins, aspirin-like drugs and analgesia. Nature New Biol 240:200-203.
12. 2. Prostaglandins 16:31-37.
13. Foreman JC (1987) Peptides and neurogenic inflammation. Br Med Bull 43:386-400.
14. Franco-Cereceda A (1989) Prostaglandins and CGRP release from cardiac sensory nerves. Naunyn Schmiedebergs Arch Pharmacol 340: 180-184.
15. Gammon CM, Allen AC, Morell P (1989) Bradykinin stimulates phosphoinositide hydrolysis and mobilization of arachidonic acid in dorsal root ganglia neurons. J Neurochem 53:95-101.
16. Gamse R, Holzer P, Lembeck F (1980) Decrease of substance P in primary afferent neurones and impairment of neurogenic plasma extravasation by capsaicin. Br J Pharmacol 68:207-213.
17. Geppetti P, Tramontana M, Santicioli P, Del Bianco E, Giuliani S, Maggi CA (1990) Bradykinin-induced release of calcitonin gene-related peptide from capsaicin-sensitive nerves in guinea-pig atria: mechanism of action and calcium requirements. Neuroscience 38: 687-692.
18. Geppetti P, Del Bianco E, Tramontana M, Vigano T, Folco GC, Maggi CA, Manzini S, Fanciullacci M (1991) Arachidonic acid and bradykinin share a common pathway to release neuropeptide from capsaicin-sensitive sensory nerve fibers of the guinea pig heart. J Pharmacol Exp Ther 259:759-765.
19. 2 in the sensitization of mechanoreceptors in normal and inflamed ankle joints of the rat. Exp Brain Res 84:383-392.
20. Handwerker HO (1976) Influences of algogenic substances and prostaglandins on the discharges of unmyelinated cutaneous nerve fibers identified as nociceptors. In: Advances in pain research and therapy, Vol 1 (Bonica JJ, Albe-Fessard D, eds), pp 41-45. New York: Raven.
21. Hargreaves KM. Troullos ES, Dionne RA, Schmidt EA, Schafer SC, Joris JL (1988) Bradykinin is increased during acute and chronic inflammation: therapeutic implications. Clin Pharmacol Ther 44:613-621.
22. Helme RD, Andrews PV (1985) The effect of nerve lesions on the inflammatory response to injury. J Neurosci Res 13:453-459.
23. Higgs GA, Salmon JA (1979) Cyclo-oxygenase products in carrageenin-induced inflammation. Prostaglandins 17:737-746.
24. Higgs GA, Moncada S, Vane JR (1984) Eicosanoids in inflammation. Ann Clin Res 16:287-299.
25. Hua X-Y, Yaksh TL (1993) Pharmacology of the effects of bradykinin, serotonin, and histamine on the release of calcitonin gene-related peptide in the rat trachea. J Neurosci 13:1947-1953.
26. Jancso N, Jancso-Gabor A, Szolcsanyi J (1967) Direct evidence for neurogenic inflammation and its prevention by denervation and by pretreatment with capsaicin. Br J Pharmacol Chemother 31:138-151.
27. Jancso N, Jancso-Gabor A, Szolcsanyi J (1968) The role of sensory nerve and paw of the rat. Br J Pharmacol Chemother 32:32-41.
28. Juan H (1978) Prostaglandins as modulators of pain. Gen Pharmacol 9:403-409.
29. Juan H, Lembeck F (1974) Action of peptides and other algesic agents on paravascular pain receptors of the isolated perfused rabbit ear. Naunyn Schmiedebergs Arch Pharmacol 283:151-164.
30. Kanaka R, Schaible HG, Schmidt RF (1985) Activation of fine articular afferent units by bradykinin. Brain Res 327:81-90.
31. Kenins P (1981) Identification of the unmyelinated sensory nerves which evoke plasma extravasation in response to antidromic stimulation. Neurosci Lett 25:137-141.
32. Kumakura S, Kamo I, Tsurufuji S (1988) Role of bradykinin in the vascular pereability response induced by carrageenin in rats. Br J Pharmacol 93:739-746.
33. Kumazawa T, Mizumura K, Minagawa M, Tsujii Y (1991) Sensitizing effects of bradykinin on the heat responses of the visceral nociceptor. J Neurophysiol 66:1819-1824.
34. Kuraishi Y, Nanayama T, Ohno H, Masabumi M, Satoh M (1988) Antinociception induced in rats by intrathecal administration of antiserum against calcitonin gene-related peptide. Neurosci Lett 92:325-329.
35. Lembeck F, Holzer P (1979) Substance P as neurogenic mediator of antidromic vasodilation and neurogenic plasma extravasation. Naunyn Schmiedebergs Arch Pharmacol 310:175-183.
36. Lembeck F, Popper H, Juan H (1976) Release of prostaglandins by bradykinin as an intrinsic mechanism of its algesic effect. Naunyn Schmiedebergs Arch Pharmacol 294:69-73.
37. Lembeck F, Donnerer J, Tsuchiya M, Nagahisa A (1992) The non-peptide tachykinin antagonist. CP-96,345, is a potent inhibitor of neurogenic inflammation. Br J Pharmacol 105:527-530.
38. 4 produces hyperalgesia that is dependent on polymorphonuclear leukocytes. Science 225:743-745.
39. Louis SM, Jamieson A, Russell JW, Dockray GJ (1989) The role of substance P and calcitonin gene-related peptide in neurogenic plasma extravasation and vasodilatation in the rat. Neuroscience 32:581-586.
40. MacLean DB, Wheeler F, Hayes L (1990) Basal and stimulated release of substance P from dissociated cultures of vagal sensory neurons. Brain Res 519:308-314.
41. Manning DC, Raja SN, Meyer RA, Campbell JN (1991) Pain and hyperalgesia after intradermal injection of bradykinin in humans Clin Pharmacol Ther 50:721-729.
42. Manzini S, Ballati L, Geppetti P, Rubini I, Meini S, Perretti F (1989) Arachidonic acid-induced bronchomotor responses are partially mediated by release of sensory neuropeptides from capsaicin-sensitive structures. Br J Pharmacol 98:1077-1079.
43. Martin HA, Basbaum AI, Kwiat GC, Goetzl EJ, Levine JD (1987) Leukotriene and prostaglandin sensitization of cutaneous high-threshold C- and A-delta mechanonociceptors in the hairy skin of rat hindlimbs. Neuroscience 22:651-659.
44. McGiff JC, Terragno NA, Malik KU, Lonigro AJ (1972) Release of prostaglandin E-like substance from canine kidney by bradykinin. Circ Res 31:36-43.
45. 2. Brain Res 225: 95-105.
46. 2 enhances the sensitivity to bradykinin in rat sensory neurons grown in culture. Soc Neurosci Abstr 18:690.
47. 2 increases calcium conductance and stimulates release of substance P in avian sensory neurons. J Neurosci 12:1917-1927.
48. Oku R, Satoh M, Fujii N, Otaka A, Yajima H, Takagi H (1987) Calcitonin gene-related peptide promotes mechanical nociception by potentiating release of substance P from spinal dorsal horn in rats. Brain Res 403:350-354.
49. Pang IH, Vasko MR (1986) Morphine and norepinephrine but not 5-hydroxytryptamine and γ-aminobutyric acid inhibit the potassium-stimulated release of substance P from rat spinal cord slices. Brain Res 376:268-279.
50. 1-induced sensitization of Aδ moderate pressure mechanoreceptors. Brain Res 232: 89-96.
51. Payan DG (1989) Neuropeptides and inflammation: the role of substance P. Annu Rev Med 40:341-352.
52. Rueff A, Dray A (1993) Sensitization of peripheral afferent fibres in the in vitro neonatal rat spinal cord-tail by bradykinin and prostaglandins. Neuroscience 54:527-535.
53. Saria A, Gamse R, Petermann J, Fischer JA, Theodorsson-Norheim E, Lundberg JM (1986) Simultaneous release of several tachykinins and calcitonin gene-related peptide from rat spinal cord slices. Neurosci Lett 63:310-314.
54. 2. J Physiol (Lond) 403:91-104.
55. Steranka LR, Manning DC, DeHass CJ, Ferkany JW, Borosky SA, Connor JR, Vavrek RJ, Stewart JM, Synder SH (1988) Bradykinin as a pain mediator: receptors are localized to sensory neurons and antagonists have analgesic actions. Proc Natl Acad Sci USA 85:3245-3249.
56. Szolcsanyi J (1988) Antidromic vasodilatation and neurogenic inflammation. Agents Actions 23:4-11.
57. 2α. Brain Res 373:81-84.
58. Taiwo YO, Levine JD (1989) Prostaglandin effects after elimination of indirect hyperalgesic mechanisms in the skin of the rat. Brain Res 492:397-399.
59. 2 in joint fluid in rheumatoid arthritis. Scand J Rheumatol 6:151-154.
60. Traub RJ, Solodkin A, Ruda MA (1989) Calcitonin gene-related peptide immunoreactivity in the cat lumbosacral spinal cord and the effects of multiple dorsal rhizotomies. J Comp Neurol 287:225-237.
61. α to conscious mice. Brain Res 510:26-32.
62. Vasko MR, Zirkelbach SL, Waite KJ (1993) Prostaglandins stimulate the release of substance P from rat spinal cord slices. Prog Pharmacol Clin Pharmacol 10:69-89.
63. Waite KJ, Vasko MR (1991) Prostaglandins stimulate the release of substance P from rat sensory neurons grown in culture. Soc Neurosci Abstr 17:1373.
64. 2 and elevation of intracellular cyclic AMP enhance bradykinin-stimulated release of peptides from rat sensory neurons in culture. Soc Neurosci Abstr 18:690.
65. 2 and the vascular changes of inflammation. Br J Pharmacol 65:517-524.
66. Williams TJ, Morley J (1973) Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 246:215-217.
67. 2 in rat paws induces chronic swelling and a marked decrease in pain threshold. Prostaglandins 3:353-357.
68. Yanagisawa M, Otsuka M, Garcia-Arraras JE (1986) E-type prostaglandins depolarize primary afferent neurons of the neonatal rat. Neurosci Lett 68:351-355.